Application no. and date | 09703808.7 (espacenet) (Federated) (European Patent Register), 20090113 | Patent/reg. no. and date | DK/EP 2252581, 20120620 | Publication date | 20101124 | Priority no. and date | EP 08380012, 20080122, US 39121 P, 20080325 | EP pub. no. and date |
EP 2252581 20101124 | Effective date | | Applicant/owner | ELI LILLY AND COMPANY, Lilly Corporate Center
Indianapolis, IN 46285, US | Applicant ref. no. | P81202893DK00E | Inventor | DIAZ BUEZO, Nuria, Lilly S.A. Avenida de la Industria 30 28108 Alcobendas
Madrid, ES, MCKINZIE, David, Lee, Eli Lilly and Company Lilly Corporate Center
Indianapolis, Indiana 46285, US, MITCH, Charles, Howard, Eli Lilly and Company Lilly Corporate Center
Indianapolis, Indiana 46285, US, PEDREGAL-TERCERO, Concepcion, Lilly S.A. Avenida de la Industria 30 28108 Alcobendas
Madrid, ES | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/40 (2006.01) , A61P 25/32 (2006.01) , C07D 207/08 (2006.01) | Title | KAPPA-SELEKTIV OPIOIDRECEPTORANTAGONIST | Int. application no. | US2009030811 | Int. publication no. | WO2009094260 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|